Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spectral expands sales of heart test:

This article was originally published in Clinica

Executive Summary

Spectral Diagnostics has expanded the European sales of its STATus point-of-care heart attack tests following the signing of three distribution agreements. Medixon will sell the tests in Israel, where it is based, as well as in Cyprus and Jordan. Greece and Turkey will be handled by Median*s agent Gerolymatos. Intex will sell the kits in Hungary, while Slovakia and the Czech Republic are to be served by Aris Jicin. The two STATus tests detect troponin-I, and CK-MB and Myoglobin.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083485

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel